These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32674074)

  • 1. Radiomics-based prediction of survival in patients with head and neck squamous cell carcinoma based on pre- and post-treatment
    Liu Z; Cao Y; Diao W; Cheng Y; Jia Z; Peng X
    Aging (Albany NY); 2020 Jul; 12(14):14593-14619. PubMed ID: 32674074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of
    Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [No Abstract]   [Full Text] [Related]  

  • 3. The Prognostic Significance of Tumor SUVmax Value in Pre- and Post-Chemoradiotherapy 18F-FDG PET/CT Imaging in Patients with Localized and Advanced Head and Neck Squamous Cell Carcinoma.
    Kandemir O; Demir F; Avcı GG
    Niger J Clin Pract; 2024 Jun; 27(6):748-753. PubMed ID: 38943299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of tumor metabolic imaging phenotype by FDG PET radiomics in HNSCC.
    Yoon H; Ha S; Kwon SJ; Park SY; Kim J; O JH; Yoo IR
    Ann Nucl Med; 2021 Mar; 35(3):370-377. PubMed ID: 33554314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of
    Song Y; Tian Y; Lu X; Chen G; Lv X
    Med Phys; 2024 Jul; 51(7):4907-4921. PubMed ID: 38252704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiomics Features on Enhanced Computed Tomography Predict FOXP3 Expression and Clinical Prognosis in Patients with Head and Neck Squamous Cell Carcinoma.
    Wang Y; Ye J; Zhou K; Chen N; Huang G; Feng G; Zhang G; Gou X
    J Imaging Inform Med; 2024 Aug; 37(4):1323-1335. PubMed ID: 38376584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of the
    Wakisaka R; Kumai T; Komatsuda H; Yamaki H; Kono M; Sato R; Ohara K; Kishibe K; Hayashi T; Okizaki A; Takahara M
    Clin Otolaryngol; 2024 Nov; 49(6):733-741. PubMed ID: 38950901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlations between DW-MRI and
    Connor S; Sit C; Anjari M; Szyszko T; Dunn J; Pai I; Cook G; Goh V
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1360. PubMed ID: 33960739
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kim SA; Roh JL; Kim JS; Lee JH; Lee SH; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET/CT Versus Standard Imaging for Prediction of Survival in Patients with Recurrent Head and Neck Squamous Cell Carcinoma.
    Rohde M; Nielsen AL; Pareek M; Johansen J; Sørensen JA; Diaz A; Nielsen MK; Christiansen JM; Asmussen JT; Nguyen N; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
    J Nucl Med; 2019 May; 60(5):592-599. PubMed ID: 30315144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic nomogram combining
    Zhang Y; Cui Y; Liu H; Chang C; Yin Y; Wang R
    Sci Rep; 2024 Sep; 14(1):20557. PubMed ID: 39231973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-treatment
    Jung AR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2020 Aug; 107():104750. PubMed ID: 32361565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of clinical and
    Cho JK; Hyun SH; Choi JY; Choi N; Kim MJ; Lee SH; Baek KH; Jeong HS
    J Surg Oncol; 2016 Dec; 114(7):888-894. PubMed ID: 27546387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
    Philip MM; Welch A; McKiddie F; Nath M
    Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: A prospective observational study.
    Ryu IS; Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Eur J Cancer; 2016 Aug; 63():88-96. PubMed ID: 27288873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Ferrari C; Santo G; Mammucci P; Rubini D; Sciacqua A; Sardaro A; Pisani AR; Rubini G
    BMC Med Imaging; 2023 Feb; 23(1):34. PubMed ID: 36814217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.